Grants and Contracts Details
Description
It is eBdmatcdthat 118.700Amerk;anwoqn wm be diagnosed with breast canca in 1998. A Jarl8
proponion of these women-iU be troattd with adjuvantchemotherapy based on evidence wbich sl1l1cSf8
.that such treatment extend. disease-tree survival u wen as overan survival. AJ more WODIOUreceive
adjuvant chemotherapy, there is a growing recognition of the potential fot' lana.term side effects. AIoD&
these Jines, it bat _n shown that 8dminJstration of adjuV8fttchemotherapymay result in secondary
leukemia, cardiotoxicit)', BDdovarian failure. CIioWaIobservations and a lDni1ednumber of ~seud1
ropons sQIICIt that many WOlDlnmay also exporleace pmisteftt fatisue as I IODl-term side L':ffcctof
adjuvant chemotherapy treatment. Althouah fatigue bas been id~tifted u otte of the molt frequent and
distressittg symptoms atfecting breast cancer patients previously treated with adjuvant chemotherapy,
zeJatively HttJeis knowa a~t its characmistfcs, etiology. or treatmem. The proposed study will address
these mwes by conducting the fl1'Stcontrolled, longitudinal study of fatigue In breast cancer patients befo~,
du.rlng,aDdaf\e:r84juvant cbemotbetapy treatment.
~Im 1: 10 determine tbe le'Yerit1, dtronJdty, and COW'Ieof fatigue U80dattd wftJI acljU't'1IDt
trutm.ent of breast aneer. Bued onpriorresearch.we hypothes!ze that fatigu~ wm worsen in breast
cancer patients upon the :initiationof adjuvant b'eatnl8nt. Levell of fatiauc are expected to ~UmJn above
pretreaumut Jevell durin. the six-JnQnthperiod IoDowinl completion of atijuvant trcttUJDdt8Dd to be
areater than levels of fatiguesreported by an ale-matched comparison group of women with no hfstmy of
oancer.
Abn Z: To ehancterlze tbe coptU'fe, aft'edlft; 88IdbeIIavloni mulfestadObl of f8tipe tItM PtI'IiIt8
tbllowiag adjuvant treatDaent of bl'l8lt C!8QCIt,Consistent with a mulddbnensio.w. colmepmaUzarion,
we hypothesize that worse fatigue among bloat cancer patients following comp1etionof ~uvant treatment
will be ISlOClated with greater copitive probJcms (copitive col'q)Iaint& and copDtive d)'sfunctton),
affective prob1ema (a.iJcctive disturbance aud a1fective disorder), and bcha\'ioral problems (physical, social,
aid tOle disability). This hypothesis will be evaluated by testina for cx~d re1at1ons between indices of
fatigue and indices of cognitive, aftective~ ad be~vior.l1imctioninl among breast cancer patients and by
determinina whether differences In cognkive, affective, and behavioral functioning between 1nut cancer
patients I11d~omparl8on subjects are mediated by fatigue.
Aim 3: To teIt the utiDt, 01 . wpitiTe~beb.vioral model d.peel to gpIadn tile perpetaatioII of
fadpe tolknrinl BCUtmnttr8tment of breast cancer. Based on cognitive~behavioral models of the
de~lQPmcnt of chronic pain and chromefatigue, ~ hypothcllze that patients' copiDgresponscsduring
adjuvant treatment wi11explain the perpetuation of fatigue foUowinl treatment completioft. S~citlcal1y,
we hJPotbeiizc that patieftu who arc mote reliant on certain maladaptive coping strateS.. (cat8SttOphiztng,
b:uaiDg on symptoms, aecomrnodatina to Illness. and fallinS to maintain activity) durin8 adjuvant
ttelltD11t wi11experience worse foDomg tl'eattn8ntcompletion. Validation of this model is exp~i1 to
lead to the adaptation and pilot testin&of Bcogniti\'e-bebavioral intervention developed for chronic fatigue
for UIR!! with CUQtf patients experlcnch\, fatipe related to chemotherapy and radiotherapy.
Status | Finished |
---|---|
Effective start/end date | 6/1/04 → 4/30/11 |
Funding
- H Lee Moffitt Cancer Center and Research Institute Hospital: $822,726.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.